The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors
Clinical trial NCT02660034 · COMPLETED
Trial details
- NCT number
- NCT02660034
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-02
- Primary completion
- 2020-09-09
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.